These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36592248)

  • 61. Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.
    Sarrazin C; Bruckner M; Herrmann E; Rüster B; Bruch K; Roth WK; Zeuzem S
    Virology; 2001 Oct; 289(1):150-63. PubMed ID: 11601926
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape Variants.
    Gottwein JM; Pham LV; Mikkelsen LS; Ghanem L; Ramirez S; Scheel TKH; Carlsen THR; Bukh J
    Gastroenterology; 2018 Apr; 154(5):1435-1448. PubMed ID: 29274866
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection.
    Wrensch F; Ligat G; Heydmann L; Schuster C; Zeisel MB; Pessaux P; Habersetzer F; King BJ; Tarr AW; Ball JK; Winkler M; Pöhlmann S; Keck ZY; Foung SKH; Baumert TF
    Hepatology; 2019 Nov; 70(5):1506-1520. PubMed ID: 31062385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural perspectives on HCV humoral immune evasion mechanisms.
    Sevvana M; Keck Z; Foung SK; Kuhn RJ
    Curr Opin Virol; 2021 Aug; 49():92-101. PubMed ID: 34091143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.
    González-Aldaco K; Torres-Reyes LA; Ojeda-Granados C; José-Ábrego A; Fierro NA; Román S
    Ann Hepatol; 2018 Oct; 17(6):908-919. PubMed ID: 30600305
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
    Morishima C; Polyak SJ; Ray R; Doherty MC; Di Bisceglie AM; Malet PF; Bonkovsky HL; Sullivan DG; Gretch DR; Rothman AL; Koziel MJ; Lindsay KL;
    J Infect Dis; 2006 Apr; 193(7):931-40. PubMed ID: 16518754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.
    Ansaldi F; Orsi A; Sticchi L; Bruzzone B; Icardi G
    World J Gastroenterol; 2014 Aug; 20(29):9633-52. PubMed ID: 25110404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis C virus genetic variability and evolution.
    Echeverría N; Moratorio G; Cristina J; Moreno P
    World J Hepatol; 2015 Apr; 7(6):831-45. PubMed ID: 25937861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphocyte Landscape after Chronic
    Ghosh A; Romani S; Kottilil S; Poonia B
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050486
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
    Qureshi SA
    Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequence diversity of hepatitis C virus: implications for immune control and therapy.
    Timm J; Roggendorf M
    World J Gastroenterol; 2007 Sep; 13(36):4808-17. PubMed ID: 17828811
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine.
    Ikram A; Obaid A; Awan FM; Hanif R; Naz A; Paracha RZ; Ali A; Janjua HA
    Antiviral Res; 2017 Jan; 137():112-124. PubMed ID: 27984060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
    Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
    Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
    mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Natural history of acute and chronic hepatitis C.
    Maasoumy B; Wedemeyer H
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):401-12. PubMed ID: 23199500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.